Evidence map›Paper›PMID 31238335›Full record

ArticlePloS one2019

In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism.

Roberta De Bellis, Maria Piera Piacentini, Maria Assunta Meli, Michele Mattioli, Michele Menotta, Michele Mari, Laura Valentini, Letizia Palomba, Donatella Desideri, Laura Chiarantini

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Unlocking New Approaches to Urolithiasis ManagementCurrent pharmaceutical biotechnology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Increased Sulfation inMarine drugs · 2022
    Article
  15. Regulation ofOxidative medicine and cellular longevity · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Roberta De BellisDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU) Italy.ORCID 0000-0001-9623-3279
Maria Piera PiacentiniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU) Italy.
Maria Assunta MeliDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU) Italy.
Michele MattioliDepartment of Pure and Applied Sciences University of Urbino Carlo Bo, Urbino (PU) Italy.ORCID 0000-0002-1672-130X
Michele MenottaDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU) Italy.ORCID 0000-0001-5206-6296
Michele MariDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU) Italy.ORCID 0000-0002-3763-3587
Laura ValentiniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU) Italy.
Letizia PalombaDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU) Italy.
Donatella DesideriDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU) Italy.ORCID 0000-0002-0858-1888
Laura ChiarantiniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU) Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ceterach officinarum Willd is a plant widespread throughout Europe and used in southern Italy as a diuretic. Beliefs in the benefits of C. officinarum aqueous extract in the treatment of calcium oxalate kidney stones are widely held. Little is known, however, about the actual mechanism of its antilithiatic action. Our results in this in vitro study corroborate C. officinarum aqueous extract as a good source of antioxidants with a high antioxidant effects. Our results also demonstrate a major impact of C. officinarum aqueous extract on in vitro induced calcium oxalate crystallization kinetics and crystal morphology, showing its critical role in kidney stone formation and/or elimination. We show that progressively increasing doses of C. officinarum aqueous extract cause a sequence of effects. A powerful inhibitory action on calcium oxalate monohydrate (COM) growth and aggregation is first observed. C. officinarum aqueous extract also appears highly effective in stimulating nucleation increasing the number and reducing the size of COM crystals, which become progressively thinner, rounded and concave in a dose-dependent manner. These shape-modified COM crystals are known to be less adherent to renal tubular cells and more easily excreted through the urinary tract preventing kidney stone formation. Further, C. officinarum aqueous extract promotes the formation of calcium oxalate dihydrate (COD) rather than the monohydrate so that, at the highest concentrations used, only COD crystals are observed, in significant greater numbers with a clear reduction in their size, in a dose-dependent manner. Furthermore, AFM analyses allowed us to reveal the presence of C. officinarum component(s) on the surfaces of COD and modified COM crystals. The crystal surface adsorbed component(s) are shown to be similarly active as the total aqueous extract, suggesting a trigger factor which may direct crystal modification towards COD forms. In urolithiasis pathogenesis COD crystals are less dangerous than the COM forms due to their lower affinity for renal tubular cells. Our results are important in understanding the mechanisms which guide the modification induced by C. officinarum on the crystallization process. Based on these data, together with no adverse toxic effect being observed on the in vitro model of human intestinal enterocytes, C. officinarum aqueous extract could represent an attractive natural therapy for the treatment of urolithiasis.

Indexed as

FernsPlants, MedicinalAntioxidantsCaco-2 CellsCalcium OxalateCrystallizationDiureticsEnterocytesHumansIn Vitro TechniquesItalyKidney CalculiKineticsMicroscopy, Atomic ForceMicroscopy, Electron, ScanningModels, ChemicalAntioxidantsCalcium OxalateDiureticsPlant Extracts

Identifiers

PMID31238335
PMCPMC6592703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.